Elacestrant

CHEMBL4297509 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

458.6 g/mol

LogP

6.3

Phase

4

This oral medication blocks estrogen receptors in breast cancer cells, slowing or stopping tumor growth in certain hormone receptor-positive cancers. It is often used when other hormonal therapies have stopped working.

Molekularmasse

458,6000 g/mol

LogP

6,30

TPSA

44,70 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Non-Small Cell Lung Cancer Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1

InChI

InChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1

Molecular Formula

C30H38N2O2

HBD / HBA

2 / 4

Rotierbare Bindungen

10

Schwere Atome

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This oral medication blocks estrogen receptors in breast cancer cells, slowing or stopping tumor growth in certain hormone receptor-positive cancers. It is often used when other hormonal therapies have stopped working.

Yes, Elacestrant is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297509. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23642301. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Elacestrant auf PillFYI

Struktur

Schnelldaten

Formel: C30H38N2O2
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.